InspireMD (NSPR) Return on Capital Employed (2011 - 2025)
InspireMD's (NSPR) quarterly Return on Capital Employed came in at 78.47% in Q4 2025, up 331.0% year-on-year from 18.21% in Q4 2024, and up 24.55% quarter-over-quarter from 104.01% in Q3 2025.
InspireMD (NSPR) Return on Capital Employed (2011 - 2025) Analysis & Trends
InspireMD's Return on Capital Employed history runs 14 years deep, the most recent figure standing at 78.47% for Q4 2025.
- On a quarterly basis, Return on Capital Employed rose 331.0% year-over-year to 78.47% in Q4 2025; TTM through Dec 2025 was 78.47%, a 331.0% increase from a year earlier, with the FY2025 full-year figure at 104.69%, down 1997.0% from the prior year.
- Return on Capital Employed rose to 78.47% in Q4 2025 per NSPR's latest filing, from 104.01% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 28.9% in Q2 2021 and bottomed at 157.05% in Q2 2025.
- The 5-year median for Return on Capital Employed is 62.63% (2024), against an average of 68.9%.
- Across the five-year window, Return on Capital Employed soared 10593 bps in 2021 and slumped 9229 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 39.98% in 2021, then slumped by 120 bps to 87.91% in 2022, then jumped by 44 bps to 49.39% in 2023, then slumped by 66 bps to 81.78% in 2024, then climbed by 4 bps to 78.47% in 2025.
- Per Business Quant, the three latest NSPR Return on Capital Employed figures stand at 78.47% (Q4 2025), 104.01% (Q3 2025), and 157.05% (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | -78.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -78.47% |
| Sep 30, 2025 | -104.01% |
| Jun 30, 2025 | -157.05% |
| Mar 31, 2025 | -106.15% |
| Dec 31, 2024 | -81.78% |
| Sep 30, 2024 | -65.37% |
| Jun 30, 2024 | -64.76% |
| Mar 31, 2024 | -60.50% |
| Dec 31, 2023 | -49.39% |
| Sep 30, 2023 | -43.00% |
| Jun 30, 2023 | -60.22% |
| Mar 31, 2023 | -103.93% |
| Dec 31, 2022 | -87.91% |
| Sep 30, 2022 | -66.94% |
| Jun 30, 2022 | -58.55% |
| Mar 31, 2022 | -47.07% |
| Dec 31, 2021 | -39.98% |
| Sep 30, 2021 | -35.57% |
| Jun 30, 2021 | -28.90% |
| Mar 31, 2021 | -38.47% |